Cell to Cure ApS is a Danish APS based in Birkerød, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2018, the company has 14 employees and reported revenue of -3,1 mio. kr. in its latest annual filing.
Selskabet tegnes af den samlede bestyrelse i forening eller af bestyrelsesformanden i forening med enten ét andet bestyrelsesmedlem eller én direktør
Company purpose
Selskabets formål er at drive virksomhed med handel, rådgivning og assistance inden for farmaceutisk og bioteknologisk industri og beslægtede brancher, samt anden dermed beslægtet virksomhed.
In its most recent annual report (2025), Cell to Cure ApS reported a gross profit of -3,1 mio. kr.. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of 9,8 mio. kr..
